CMS To Cover Some Costs For Astigmatism-Correcting Intraocular Lenses
This article was originally published in The Gray Sheet
Executive Summary
Alcon says a Jan. 22 1ruling from CMS provides just the leg up it needed to boost sales of its astigmatism-correcting intraocular lens, the AcrySof Toric
You may also be interested in...
Staar Shakes Up U.S. Sales Force, Separating Cataract And Refractive Teams
Staar Surgical is separating its U.S. refractive and cataract product sales teams as part of a major restructuring intended to reverse the recent decline in the company's domestic revenues
Staar Shakes Up U.S. Sales Force, Separating Cataract And Refractive Teams
Staar Surgical is separating its U.S. refractive and cataract product sales teams as part of a major restructuring intended to reverse the recent decline in the company's domestic revenues
Alcon Stock Gains From CMS Decision, New Products – MDDI Index
CMS' decision to expand Medicare coverage to Alcon's AcrySof ReStor intraocular lens enhanced investor confidence in the device and helped push the stock up 22.5% for the second quarter